Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06255613 · ClinicalTrials.gov registry record · NA
Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor
A NA study of Sleep Disordered Breathing and Arrhythmia, sponsored by Belun Technology Company Limited.
- Active
- Registry status
- NA
- Development phase
- 79
- Enrollment target
- 2
- Study locations
NCT06255613 is a NA study of Sleep Disordered Breathing and Arrhythmia that is active but no longer recruiting, run by Belun Technology Company Limited. The registered enrollment target is 79 participants, below the 194-participant average among 19 other Sleep Disordered Breathing trials with a reported enrollment target (59% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06255613, a NA study of Sleep Disordered Breathing and Arrhythmia, is active but no longer recruiting, sponsored by Belun Technology Company Limited.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
- 2
- Study locations
Study Summary
Hypothesis: BR's Gen3 DL algorithms, combined with its subxiphoid body sensor, can accurately diagnose OSA, categorize its severity, identify REM OSA and supine OSA, and detect central sleep apnea (CSA). Primary Objective: To rigorously evaluate the overall performance of the BR with Gen3 DL Algorithms and Subxiphoid Body Sensor in assessing SDB in individuals referred to the sleep labs with clinical suspicion of sleep apnea and a STOP-Bang score \> 3, by comparing to the attended in-lab PSG, the gold standard. Secondary Objectives: To determine the accuracy of BR sleep stage parameters using the Gen3 DL algorithms by comparing to the in-lab PSG; To assess the accuracy of the BR arrhythmia detection algorithm; To assess the impact of CPAP on HRV (both time- and frequency-domain), delta HR, hypoxic burden, and PWADI during split night studies; To assess if any of the baseline HRV parameters (both time- and frequency-domain), delta heart rate (referred to as Delta HR), hypoxic burden, and pulse wave amplitude drop index (PWADI) or the change of these parameters may predict CPAP compliance; To evaluate the minimum duration of quality data necessary for BR to achieve OSA diagnosis; To examine the performance of OSA screening tools using OSA predictive AI models formulated by National Taiwan University Hospital (NTUH) and Northeast Ohio Medical University (NEOMED).
Conditions Studied
Interventions
- DEVICE Belun Ring
- DEVICE Belun Cor
Study Locations (2)
Ohio
- UH Geauga Health Center Services - Chardon
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2024-07-19 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06255613
The ClinicalTrials.gov registry entry for NCT06255613 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 194-participant average among 19 other Sleep Disordered Breathing trials with a reported enrollment target (59% lower). The listed sponsor is Belun Technology Company Limited, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sleep Disordered Breathing appearing as the primary indexed condition, and to 2 interventions - of which Belun Ring is the first listed.
NCT06255613 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06255613 about?
NCT06255613 is a clinical study titled "Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor". Hypothesis: BR's Gen3 DL algorithms, combined with its subxiphoid body sensor, can accurately diagnose OSA, categorize its severity, identify REM OSA and supine OSA, and detect central sleep apnea (CSA). Primary Objective: To rigorously evaluate the overall performance of the BR with Gen3 DL Algor...
What is the current status of trial NCT06255613?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 79 participants. The study started on 2024-07-19. Estimated completion is 2027-09-30.
What conditions does trial NCT06255613 study?
This clinical trial studies the following conditions: Sleep Disordered Breathing, Arrhythmia, Sleep Architecture.
What interventions are being tested in trial NCT06255613?
The interventions under investigation include: Belun Ring (DEVICE), Belun Cor (DEVICE).
Who is sponsoring clinical trial NCT06255613?
This trial is sponsored by Belun Technology Company Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06255613 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disordered Breathing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Belun Ring Platform With an Improved Algorithm for OSA Assessment
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
Sleepiness and the Effects of CPAP on Salivary Cortisol and Alpha-Amylase Levels in Patients With Sleep Apnea
COMPLETED · NA
-
Impact of Exenatide on Sleep in Type 2 Diabetes
COMPLETED · NA
-
Efficacy of Clinical Decision Support and Sleep Navigation (Sleep PASS)
COMPLETED · NA
-
Treatment of Sleep-disordered Breathing in Patients With SCI
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.